Table 1.
lncRNA | lncRNA alias | Cancer | Stress type | Role | Reference |
---|---|---|---|---|---|
MACC1-AS1 | MACC1-AS1 | Gastric | Metabolic | Pro-Oncogenic | (17) |
GLCC1 | AF339830 | Colorectal | Metabolic | Pro-Oncogenic | (18) |
SAMMSON | SAMMSON | Melanoma | Metabolic | Pro-Oncogenic | (19) |
FILNC1 | FILNC1 | Renal | Metabolic | Anti-Oncogenic | (20) |
IDH1-AS1 | IDH-AS1 | Colon/Cervical | Metabolic | Anti-Oncogenic | (21) |
NBR2 | NBR2 | Breast | Metabolic | Anti-Oncogenic | (22) |
HAND2-AS1 | HAND2-AS1 | Osteosarcoma | Metabolic | Anti-Oncogenic | (23) |
H19 | H19 | Cholangiocarcinoma/ Pituitary | Metabolic/Oxidative | Both Pro and Anti Oncogenic | (24, 25) |
HULC | HULC | Cholangiocarcinoma | Oxidative | Pro-Oncogenic | (25) |
NLUCAT1 | Lnc-ARRDC3-1 | Lung adenocarcinoma | Oxidative | Pro-Oncogenic | (26) |
NONHSAT1010169 | NOAT113026 | Breast | Genotoxic | Pro-Oncogenic | (27) |
GUARDIN | LNCTAM34A | Breast | Genotoxic | Pro-Oncogenic | (28) |
NEAT1 | NEAT1 | Multiple Myeloma | Genoxtoxic | Pro-Oncogenic | (29) |
BORG | BMP/OP-responsive gene | Breast | Genotoxic | Pro-Oncogenic | (30) |
PRAL | PRAL | Hepatocellular Carcinoma | Genotoxic | Anti-Oncogenic | (31) |
LOC572558 | HSALNT0149810 | Bladder | Genotoxic | Anti-Oncogenic | (32) |
LincRNA-p21 | TP53COR1 | Lung/Sarcoma/Lymphoma | Genotoxic | Anti-Oncogenic | (13, 33) |
PANDA | PANDAR | Bone | Genotoxic | Anti-Oncogenic | (34) |